Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Technology Scientific & Technical Instruments

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Resistance at .38

<< Previous

Bullboard Posts

Next >>

Comment by stockmonster6on Mar 08, 2021 12:33pm

151 Views

Post# 32743784

RE:RE:RE:RE:RE:RE:RE:Resistance at .38

My hunch is that, they would release results of this 100/300 test combined with a statement about HC approval. HC approval can take up to 45 days, could be fast tracked.

then a NR on reception of HC approval.
then a NR on manufacturing/ contracts etc...

However, I could be wrong. They could wait, get the test results and apply to HC then launch a release once HC approval is given. But seeing the trend, they will likely update each step of the way

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo